Earlier quoted context omitted.
> Because whether they make 100x or 200x they make a shitload of money. It's not a certainty that they 'make a shitload of money'. Reducing the right tail payoffs absolutely reduces the capital allocated to solve problems - many of which are risky bets . Your solution absolutely decreases capital investment at the margin, this is indisputable and basic economics. Even worse when the taking is not due to some pre-exis…
You can't just look at the costs to an action, you also have to look at the benefits. Of course I agree I'm going to stop marginal investments from occurring into research into patent-able technologies by reducing the expect profit. But I'm going to do so very slightly because I'm not shifting the expected value by very much. Meanwhile I'm going to greatly increase the investment into the existing technology we alrea…
I think you're shifting it by a lot. If the government can post-hoc decide to invalidate patents because the holder is getting too successful, you are introducing a substantial impact on expectations and uncertainty. Your action is not taken in a vacuum.
> Meanwhile I'm going to greatly increase the investment into the existing technology we already have, and allow many more people to try to improve upon it, and I'm going to argue the benefits greatly outweigh the costs.
I think this is a much more speculative impact. Why will people even fund the improvements if the government might just decide they've gotten too large a slice of the pie later on down the road?
> the trade-off I get for this is that society gets the benefit of the same actually happening in the future and us not being hamstrung by unbreachable monopolies.
No the trade-off is that materially less is produced. These incentive effects are not small. Take for instance, drug price controls - a similar post-facto taking because we feel that the profits from R&D are too high. Introducing proposed price controls leads to hundreds of fewer drugs over the next decade [0] - and likely millions of premature deaths downstream of these incentive effects. And that's with a policy with a clear path towards short-term upside (cheaper drug prices). Discounted GPUs by invalidating nvidia's patents has a much more tenuous upside and clear downside.
[0]: https://bpb-us-w2.wpmucdn.com/voices.uchicago.edu/dist/d/312...